The American Association of Clinical Endocrinology advocates for improved access to these evidence-based therapies, particularly for patients with cardiovascular disease or obesity-related complications where clinical benefits are well-established
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Perna S., Alalwan T.A., Alaali Z., Alnashaba T., Gasparri C., Infantino V., Hammad L., Riva A., Petrangolini G., Allegrini P
Its much less potent than GLP-1s, but the muscle-sparing effect is important, as one-third of the weight lost on GLP-1s is muscle mass
How PlexusDx Supports a More Personalized Approach PlexusDx genetic and biomarker insights may help provide context on how individual predispositions in GLP-1 signaling and metabolic pathways relate to perimenopause treatment planning
De Vadder, F
At Cape Fear Physical Medicine and Rehab, our experienced providers offer Qsymia and other weight management options